跳至主要内容
临床试验/IRCT20191018045149N1
IRCT20191018045149N1已完成3 期

Evaluating the effect of lycopene on cardic biomarkers, Inflammatory factors and Matrix metalloproteinase 9 in patients undering elective Percutaneous Coronary Intervention

Esfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • Patient undergoing elective PCI surgery over 40 years old.
  • Consumption of 80 to 100 mg aspirin daily for at least 5 days before PCI
  • Completion of informed consent
  • No Consumption of other antioxidants including vitamins C and E, coenzyme Q10, selenium, anthocyanin supplements and lycopene supplements 1 week before study
  • No use of fish oil and omega-3 by 1 week before study

排除标准

  • 未提供

研究者

相似试验